Neurochemical evidence for differential effects of acute and repeated oxytocin administration

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Molecular Psychiatry

• Publication date

  2018-09-27

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1038/s41380-018-0249-4PMID 30262887
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical potential of oxytocin in autism spectrum disorder: current issues and future perspectives

  2018cited by this paper
• Oxytocin and Autism Spectrum Disorders.

  2018cited by this paper
• Activation of Supraoptic Oxytocin Neurons by Secretin Facilitates Social Recognition.

  2017cited by this paper
• Promising evidence and remaining issues regarding the clinical application of oxytocin in autism spectrum disorders

  2016cited by this paper
• Clinical and neural effects of six-week administration of oxytocin on core symptoms of autism.

  2015cited by this paper
• The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial.

  2015cited by this paper
• NR2B subunit in the prefrontal cortex: A double-edged sword for working memory function and psychiatric disorders.

  2015cited by this paper
• Can oxytocin treat autism?

  2015cited by this paper
• Double Dissociation of the Roles of Metabotropic Glutamate Receptor 5 and Oxytocin Receptor in Discrete Social Behaviors

  2015cited by this paper
• Activation of presynaptic oxytocin receptors enhances glutamate release in the ventral hippocampus of prenatally restraint stressed rats.

  2015cited by this paper
• Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders.

  2015cited by this paper
• Mitigation of sociocommunicational deficits of autism through oxytocin-induced recovery of medial prefrontal activity: a randomized trial.

  2014cited by this paper
• Oxytocin improves behavioural and neural deficits in inferring others' social emotions in autism.

  2014cited by this paper
• Long-term exposure to intranasal oxytocin in a mouse autism model

  2014cited by this paper
• Oxytocin's neurochemical effects in the medial prefrontal cortex underlie recovery of task-specific brain activity in autism: a randomized controlled trial

  2014cited by this paper
• An Oxytocin-Induced Facilitation of Neural and Emotional Responses to Social Touch Correlates Inversely with Autism Traits

  2014cited by this paper
• Therapeutic interventions with oxytocin: current status and concerns.

  2013cited by this paper
• Prosocial effects of oxytocin in two mouse models of autism spectrum disorders.

  2013cited by this paper
• Long-Term Administration of Intranasal Oxytocin Is a Safe and Promising Therapy for Early Adolescent Boys with Autism Spectrum Disorders

  2013cited by this paper
• Effects of intranasal oxytocin on the neural basis of face processing in autism spectrum disorder.

  2013cited by this paper
• Oxytocin enhances brain function in children with autism

  2013cited by this paper
• Chronic intranasal oxytocin causes long-term impairments in partner preference formation in male prairie voles.

  2013cited by this paper
• Integrative Approaches Utilizing Oxytocin to Enhance Prosocial Behavior: From Animal and Human Social Behavior to Autistic Social Dysfunction

  2012cited by this paper
• Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial

  2012cited by this paper
• Absence of age-related prefrontal NAA change in adults with autism spectrum disorders

  2012cited by this paper
• Elevated Glutamatergic Compounds in Pregenual Anterior Cingulate in Pediatric Autism Spectrum Disorder Demonstrated by 1H MRS and 1H MRSI

  2012cited by this paper
• Non-Invasive Evaluation of the GABAergic/Glutamatergic System in Autistic Patients Observed by MEGA-Editing Proton MR Spectroscopy Using a Clinical 3 Tesla Instrument

  2011cited by this paper
• Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients.

  2010cited by this paper
• Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders.

  2010cited by this paper
• Promoting social behavior with oxytocin in high-functioning autism spectrum disorders

  2010cited by this paper
• NMDA Receptor GluN2B (GluRε2/NR2B) Subunit Is Crucial for Channel Function, Postsynaptic Macromolecular Organization, and Actin Cytoskeleton at Hippocampal CA3 Synapses

  2009cited by this paper
• N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.

  2007cited by this paper
• What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update

  2006cited by this paper
• NMDA-receptor mediated efflux of N-acetylaspartate: physiological and/or pathological importance?

  2004cited by this paper
• A Comparison of Some Metabolic Effects of N-Methylaspartate Stereoisomers, Glutamate and Depolarization: A Multinuclear MRS Study

  2002cited by this paper
• Risperidone in children with autism and serious behavioral problems.

  2002cited by this paper
• The emerging role of glutamate in the pathophysiology and treatment of schizophrenia.

  2001cited by this paper
• Postmortem brain abnormalities of the glutamate neurotransmitter system in autism

  2001cited by this paper
• Subunit- and site-specific pharmacology of the NMDA receptor channel.

  1999cited by this paper
• The effect of N-acetylaspartate on the intracellular free calcium concentration in NTera2-neurons.

  1995cited by this paper
• Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders

  1994cited by this paper
• Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs

  1992cited by this paper
• Austism diagnostic observation schedule: A standardized observation of communicative and social behavior

  1989cited by this paper
• WAIS-R manual : Wechsler adult intelligence scale-revised

  1981cited by this paper

• Neuropeptidergic systems in psychiatric disorders

  2026cites this paper
• Intranasal Drug Delivery in Neuropharmacology: Advances in Brain-Targeted Therapies and Bioethical Challenges

  2026cites this paper
• Mediating Impact of Intranasal Oxytocin on the Interaction Between Irritability and Reactive Aggression in Youth with Severe Irritability

  2025cites this paper
• Chronic intranasal oxytocin alleviates cognitive impairment and reverses oxytocin signaling upregulation in MK801-induced mice.

  2024cites this paper
• Oxytocin-induced increases in cytokines and clinical effect on the core social features of autism: Analyses of RCT datasets.

  2024cites this paper
• Results of a phase Ib study of SB-121, an investigational probiotic formulation, a randomized controlled trial in participants with autism spectrum disorder

  2023cites this paper
• Intranasal oxytocin in a genetic animal model of autism

  2023cites this paper
• Is the efficacy of oxytocin for autism diminished at higher dosages or repeated doses?: Potential mechanisms and candidate solutions.

  2023cites this paper
• The dopamine hypothesis of autism spectrum disorder: A comprehensive analysis of the evidence.

  2023cites this paper
• Effects of Chronically Exogenous Oxytocin on Ovary and Uterus: A Comparison of Intraperitoneal and Intranasal Administration.

  2023cites this paper
• Lower Availability of Mitochondrial Complex I in Anterior Cingulate Cortex in Autism: A Positron Emission Tomography Study.

  2022cites this paper
• Effect of a novel nasal oxytocin spray with enhanced bioavailability on autism: a randomized trial.

  2022cites this paper
• Infrequent intranasal oxytocin followed by positive social interaction improves symptoms in autistic children: a randomized clinical trial

  2022cites this paper
• Results of a phase Ib study of SB-121, an investigational probiotic formulation, in participants with autism spectrum disorder

  2022cites this paper
• Phosphorylation-dependent positive feedback on the oxytocin receptor through the kinase PKD1 contributes to long-term social memory

  2022cites this paper
• The oxytocin system and early‐life experience‐dependent plastic changes

  2021cites this paper
• Temporal analysis of individual ethanol consumption in socially housed mice and the effects of oxytocin

  2021influential citation
• Examining the effect of chronic intranasal oxytocin administration on the neuroanatomy and behavior of three autism-related mouse models

  2021cites this paper
• A randomized controlled trial of intranasal oxytocin in Phelan-McDermid syndrome

  2021cites this paper
• Repeated oxytocin prevents central sensitization by regulating synaptic plasticity via oxytocin receptor in a chronic migraine mouse model

  2021cites this paper
• Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder.

  2021cites this paper
• Competitiveness and individual characteristics: a double-blind placebo-controlled study using oxytocin

  2020cites this paper
• One Single Nucleotide Polymorphism of the TRPM2 Channel Gene Identified as a Risk Factor in Bipolar Disorder Associates With Autism Spectrum Disorder in a Japanese Population

  2020cites this paper
• A randomized trial shows dose-frequency and genotype may determine the therapeutic efficacy of intranasal oxytocin

  2020cites this paper
• The role of oxytocin and vasopressin dysfunction in cognitive impairment and mental disorders.

  2020cites this paper
• Oxytocin-induced increase in N,N-dimethylglycine and time course of changes in oxytocin efficacy for autism social core symptoms

  2020cites this paper
• Neurochemical effects of oxytocin in people at clinical high risk for psychosis.

  2019cites this paper
• Genotype and dose-frequency determine acute and chronic effects of oxytocin on amygdala fear responses in humans: therapeutic implications

  2019cites this paper
• Acute and repeated intranasal oxytocin differentially modulate brain-wide functional connectivity

  2019cites this paper
• Quantitative facial expression analysis revealed the efficacy and time course of oxytocin in autism.

  2019cites this paper
• Emerging pharmacological therapies in fragile X syndrome and autism.

  2019cites this paper
• On oxytocin and social behavior

  2018cites this paper
• Genotype and dose-frequency may critically determine the therapeutic efficacy of chronic oxytocin treatment in humans

  2018cites this paper
• Oxytocin effects on brain and behavior are influenced by dose-frequency and receptor genotype: therapeutic implications

  2018cites this paper